Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma

Gosney, J R; Gosney, M A; Lye, M; Butt, S A
February 1995
Thorax;Feb1995, Vol. 50 Issue 2, p116
Academic Journal
No abstract available.


Related Articles

  • Neuroendocrine Carcinoma of the Breast - Real versus Mimic. Kaul, Ananya; Joshi, Megha; Kapur, Lucy H.; Owens, Clarence; Roychowdhury, Monika // Journal of Krishna Institute of Medical Sciences (JKIMSU);Jan-Mar2016, Vol. 5 Issue 1, p116 

    Primary neuroendocrine carcinoma of the breast is a rare entity and is difficult to differentiate from invasive ductal carcinoma with neuroendocrine differentiation especially on small core biopsy specimens. Here we present one such challenging case of a 69 years old female who presented with...

  • Neuroendocrine Tumors of the Lung. Fisseler-Eckhoff, Annette; Demes, Melanie // Cancers;Sep2012, Vol. 4 Issue 3, p777 

    Neuroendocrine tumors may develop throughout the human body with the majority being found in the gastrointestinal tract and bronchopulmonary system. Neuroendocrine tumors are classified according to the grade of biological aggressiveness (G1-G3) and the extent of differentiation...

  • Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma. Thuy Nguyen; Phillips, Daniel; Jain, Dhanpat; Torbenson, Michael; Tsung-Teh Wu; Yeh, Matthew M.; Kakar, Sanjay // Archives of Pathology & Laboratory Medicine;Aug2015, Vol. 139 Issue 8, p1028 

    Context.--Several immunohistochemical markers are available to establish the diagnosis of hepatocellular carcinoma. Judicious selection is essential to achieve a reliable diagnosis in limited tissue provided by liver biopsy. Objective.--To compare the efficacy of 5 hepatocellular markers for the...

  • BIOPSY, LUNG  // Davis's Comprehensive Handbook of Laboratory & Diagnostic Tests ;Jan2006, p233 

    A biopsy of the lung is performed to obtain lung tissue for examination of pathologic features. The specimen can be obtained transbronchially or by open lung biopsy. In a transbronchial biopsy, forceps pass through the bronchoscope to obtain the specimen. In a transbronchial needle aspiration...

  • Neuroendocrine carcinoma of the tongue. Esmati, Ebrahim; Babaei, Mohammad; Matini, Amirhassan; Mirai Ashtiani, Monir Sadat; Hamed, Ehsan Akbari; Nosrati, Hassan; Razi, Farideh; Ganjalikhani, Maryam; Ashtiani, Monir Sadat Mirai // Journal of Cancer Research & Therapeutics;Jul-Sep2015, Vol. 11 Issue 3, Special section p659 

    Neuroendocrine carcinoma usually originates from lung. Few data exist in the literature regarding neuroendocrine carcinoma of the tongue. Patient data including history, surgical procedure, histology, and radiology investigations were collected and summarized. A 40-year-old woman was referred...

  • Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma. Wachter, David L.; Hartmann, Arndt; Beckmann, Matthias W.; Fasching, Peter A.; Hein, Alexander; Bayer, Christian M.; Agaimy, Abbas // BioMed Research International;2014, Vol. 2014, p1 

    Background. Carcinomas of the breast with neuroendocrine features are incorporated in the World Health Organization classification since 2003 and include well-differentiated neuroendocrine tumors, poorly differentiated neuroendocrine carcinomas/small cell carcinomas, and invasive breast...

  • Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid. Hirsch, Michelle S.; Faquin, William C.; Krane, Jeffrey F. // Modern Pathology;Jun2004, Vol. 17 Issue 6, p631 

    Moderately differentiated neuroendocrine carcinoma/atypical carcinoid tumor is the most common nonsquamous malignancy in the larynx; however, due to morphologic overlap and calcitonin immunoreactivity, it can be difficult to distinguish from thyroid medullary carcinoma. Currently, low serum...

  • Low-Grade Neuroendocrine Carcinoma (Carcinoid Tumor) of the Prostate. Reyes, Adriana; Moran, Cesar A. // Archives of Pathology & Laboratory Medicine;Dec2004, Vol. 128 Issue 12, pe166 

    A case of primary, prostatic, low-grade neuroendocrine carcinoma (carcinoid tumor) is described. The patient is an 86-year-old man who presented with symptoms of gross hematuria of several days' duration. Physical examination and a bladder biopsy specimen revealed the presence of a primary...

  • Value of Cytology in Small Cell Lung Carcinoma Diagnostic - Single-Center Study. Miličić, Valerija; Prvulović, Ivana; Mišić, Maja; Perić, Marija; Samardžić, Senka; Tomić, Karla // Collegium Antropologicum;2014, Vol. 38 Issue 2, p611 

    Small cell carcinoma oft5he lung (SCLC) together with the large cell neuroendocrine carcinoma (LCNEC), typical carcinoid (TC), and atypical carcinoid (AC) make a group of morphologically identifiable neuroendocrine tumors. The differential diagnosis of SCLC includes, first of all, other...

  • Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters. Gary M K Tse, Lisa; Tony K F Ma, Lisa; Winnie C W Chu, Lisa; Wynnie W M Lam, Lisa; Cycles S P Poon, Lisa; Wing-Cheong Chan, Lisa // Modern Pathology;May2004, Vol. 17 Issue 5, p568 

    Mucinous carcinoma of the breast is a specific good prognostic type malignancy occurring in elderly patients. Neuroendocrine differentiation has long been described in mucinous carcinoma, but the significance of such finding is uncertain. We evaluated the neuroendocrine differentiation profiles...


Read the Article


Sign out of this library

Other Topics